NEED TO KNOW A new study has found people who stop using weight-loss injections are likely to regain the weight they have lost in under two years The research, published by the British Medical Journal (BMJ), also found that on average those who have been using the drugs regain 0.4kg (approximately 0.88 lbs.) a month after stopping the medication The study looked at GLP-1 weight-loss medication semaglutide, sold under brand names Ozempic and Wegovy, and tirzepatide, which is sold under brand names Mounjaro and Zepbound Those taking weight-loss drugs are likely to regain the weight they have lost within two years of stopping the medication, a new study has found
Front desk staff can spend more time helping those with more complicated questions
In practice, clinicians may see weight stay stable or decrease slightly, especially alongside nutrition changes
These do not reduce the cholesterol-lowering effect
The vendor evaluation guide covers the criteria for assessing peptide suppliers, including third-party testing, purity standards, and transparent certificate of analysis documentation